FGF2 and neoplasm: Also, treatment of tumors with IFN-β, encoded by an adenoviral vector, promotes an increase in inducible nitric oxide synthase (iNOS) and a decrease in bFGF and TGF-β1 levels [129], resulting in inhibition of tumor growth.